BHV Pharma Report issue

For profit Phase 2
Founded: Raleigh NC United States (2010)
Status: Acquired by Islet Sciences (2014)

Organization Overview

First Clinical Trial
2015
NCT02537470
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree